Morgan Stanley Trims Earnings Estimates for BUD APAC, Keeps Overweight Rating and HK$9 Target

Stock News
02/16

Morgan Stanley has incorporated BUD APAC's 2025 results and 2026 guidance into its forecasts. The firm has lowered its profit estimates for the company for the current and next fiscal years by 12% and 14%, respectively. Morgan Stanley introduced an earnings per share forecast of 6 cents for BUD APAC for 2028. It maintained an "Overweight" rating on the stock and extended its valuation base to 2026, keeping the target price at HK$9.

Due to an increased proportion of at-home consumption channels in China, the firm has reduced its average selling price forecast for 2026-2027 by 2% to 3%. This adjustment led to a decrease in the gross margin forecast for 2026 and 2027 by 1.1 and 2 percentage points, respectively. Morgan Stanley also raised its forecast for the sales, general, and administrative expense ratio, reflecting investments related to the channel shift in China and commercial investments in eastern and western regions.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10